Patient-collected tongue, nasal, and mid-turbinate swabs for SARS-CoV-2 yield equivalent sensitivity to health care worker collected nasopharyngeal swabs

Author:

Tu YP,Jennings R,Hart B,Cangelosi GA,Wood RC,Wehber K,Verma P,Vojta D,Berke EM

Abstract

ABSTRACTBackgroundCurrent testing for SARS-CoV-2 requires health care workers to collect a nasopharyngeal (NP) sample from a patient. NP sampling requires the use of personal protective equipment that are in limited supply, is uncomfortable for the patient, and reduces clinical efficiency. This study explored the equivalency of patient-collected tongue, anterior nares (nasal), and mid-turbinate (MT) samples to health care worker-collected NP samples for detecting SARS-CoV-2.MethodsPatients presenting to five urgent care facilities with symptoms indicative of an upper respiratory infection provided self-collected samples from three anatomic sites along with a health care worker-collected NP sample. Using NP as the comparator, sensitivities and one-sided 95% confidence intervals for the tongue, nasal, and MT samples for detection of SARS-CoV-2 were calculated.ResultsThe sensitivity for detecting SARS-CoV-2 in patient-collected tongue, nasal, and mid-turbinate samples was 89.8% (95% CI: 80.2 -100.0), 94.0 (95% CI: 84.6-100.0) and 96.2 (95% CI: 87.7-100.0), respectively. Among samples yielding positive results, cycle threshold (Ct) values (a measure of viral load) had correlation coefficients of 0.48, 0.78, and 0.86 between the NP samples and the tongue, nasal, and MT samples, respectively.ConclusionsPatient-collected nasal and MT samples demonstrated high sensitivity for SARS-CoV-2 detection using health care worker-collected NP samples as the comparator. Among patients testing positive with NP samples, nasal and MT Ct values demonstrated high correlations with those Ct values of the NP samples. Patient-collected nasal or MT sampling may improve efficiency for COVID-19 testing while reducing the risk of exposure of the health workforce.

Publisher

Cold Spring Harbor Laboratory

Reference18 articles.

1. CDC. Coronavirus Disease 2019 (COVID-19). Centers for Disease Control and Prevention. 2020. [cited 2020 Mar 22] (https://www.cdc.gov/coronavirus/2019-ncov/index.html)

2. California Department of Public Health. CDPH Guidance for Prioritization of Patients for Laboratory Testing for COVID-19. [cited 2020 Mar 22](https://www.cdph.ca.gov/Programs/CID/DCDC/Pages/COVID-19/GuidanceforPrioritizationofPatientsforLaboratoryTestingforCOVID19.aspx)

3. New York State Department of Health. COVID-19 Testing [cited 2020 Mar 22] (https://coronavirus.health.ny.gov/covid-19-testing)

4. Woolhouse M , Rambaut A , Kellam P. Lessons from Ebola: improving infectious disease surveillance to inform outbreak management. Science Translational Medicine; 7(307): 307rv5.

5. CDC. Interim Guidelines for Collecting, Handling and Testing Clinical Speciments from Persons for Coronavirus Disease 2019 (COVID-19). 2020. [cited 2020 Mar 21] (https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3